Jiangsu Simcere Pharmaceutical Co., Ltd.

This study is testing whether a new drug called SIM0270, when combined with an existing medication (everolimus), works better than standard treatments for advanced breast cancer. It's for people with ER+/HER2- breast cancer that has spread and has stopped responding to previous h…

This is the first time a new drug called SIM0609 is being tested in people. The main goals are to find a safe dose and see how the body processes it. The study will also look for early signs that the drug might help shrink tumors in adults with advanced solid cancers who have no …

This is the first study in people to test a new cancer drug called SIM0610. It aims to find a safe dose and see if it can shrink tumors in adults with advanced solid cancers that have stopped responding to standard treatments. The study will enroll 260 people with cancers like lu…

This early-stage trial is testing a new experimental antibody called SIM0500 in adults with advanced multiple myeloma that has returned or stopped responding to all standard treatments. The study aims to find a safe dose and see if the treatment shows early signs of fighting the …

This study is testing whether adding a new drug called Suvemcitug to a standard chemotherapy pill works better than the pill alone for people with advanced colorectal cancer that has stopped responding to other treatments. About 464 participants will be randomly assigned to recei…

This early-stage study aims to understand how a new drug called SIM0270 interacts with other common medications in the body. Researchers will enroll 60 healthy Chinese adults to measure how SIM0270's levels in the blood change when taken with other drugs. The goal is to gather ba…